Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by wildbird1on Oct 21, 2019 11:37am
177 Views
Post# 30251270

RE:Oncore

RE:OncoreJust an hypothesis...

The 5 year agreement is between Oncore and SZLS.

The 6 year agreement is between Oncore and Bodycheck.

The fact that Oncore is going ahead with a 6 year agreement could indicate that oncore is confident in it's capability to fulfill it's 1,750,000 test over 5 years, and very confident the 5 year agreement will be renewed, after all Oncore has been with SZLS for just a few months and has already signed multi-year agreement that could be worth US 40 million.
For Oncore to sign a 6 year agreement, Oncore  must have an agreement with SZLS that if they reach there goal(1,750,000 tests) the agreement will be renewed.

In the June 10, 2019 PressRelease, Oncore  CEO (Saddiqui) said (QUOTE) " We have been researching various diagnostic technologies, and the science behind ColonSentry is extraordinary and ahead of any competitors by" far " (End Of Quote).

"Extraordinary, ahead,by far" These word indicate confidence in SZLS ColonSentry test.


brad129 wrote: Question for the board if Oncore has a 5 year deal with Stagezero, how can they award a six year contract with their partners?


Bullboard Posts